Latest results presented by investigators at the CROI meeting in February in Boston suggested that treatment with abacavir (also found in the combination pills Kivexa and Trizivir) and ddI (didanosine, Videx) may significantly increase the risk of myocardial infarction, or heart attack.
DdI
Getting spine: the nucleoside backbone
From the December 2005 issue of Positive Living
Nucleoside analogues are the backbone of successful anti-HIV treatments. This article examines some of the issues involved in selecting the best nucleoside backbone.
Beyond the barbs
From the December 2004 issue of Positive Living
Peripheral neuropathy (PN) is a debilitating treatment side effect and one of the common reasons for people stopping their anti-HIV medication. People’s experience of this form of neuropathy varies from a mild ‘pins and needles’ sensation or numbness in the hands and feet to very severe pain – “it’s like I’m trying to walk with broken glass in my feet”. The dog who gave his life so that Mark Latham could live
From the August 2004 issue of Positive Living
Pancreatitis is in the news. With opposition leader Mark Latham struck down by this painful condition, we look at the role of the pancreas and at HIV-related pancreatitis.
The power of one
From the December 2003 issue of Positive Living
We all want simpler treatment regimens with fewer side effects and no meal restrictions, right? Well how does once-a-day treatment sound? As PAUL KIDD reports, it may be closer than you think. Positive Aspirations: HIV, representation and stigma
From the February 2003 issue of Positive Living
Representations of positive people in the media. By Sean Slavin.